Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06375434

Correlation Between Gut Microbiota and Radiosensitivity of Rectal Cancer

The Mechanistic Study on the Influence of Gut Microbiota on Radiotherapy Sensitivity in Patients With Locally Advanced Rectal Cancer

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Jing-kun Liu · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

The purpose of this process is to clarify the characteristics of gut microbiota changes in patients with locally advanced rectal cancer undergoing preoperative neoadjuvant treatment, and to identify key bacterial species closely related to sensitivity to radiotherapy. This aims to elucidate the mechanism linking gut microbiome dysbiosis with radiotherapy sensitivity, thereby providing new combined treatment strategies to enhance the efficacy of radiotherapy.

Detailed description

The study is expected to enroll 100 patients with locally advanced rectal cancer, including 50 patients in the radiotherapy-sensitive group and 50 in the radiotherapy-resistant group. Each participant will provide stool and blood samples before treatment for subsequent metagenomic and metabolomic sequencing analysis.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2024-05-15
Primary completion
2024-08-15
Completion
2024-08-31
First posted
2024-04-19
Last updated
2024-04-19

Source: ClinicalTrials.gov record NCT06375434. Inclusion in this directory is not an endorsement.